Lipid rafts mediate the synaptic localization of alpha-synuclein.

Article Details

Citation

Fortin DL, Troyer MD, Nakamura K, Kubo S, Anthony MD, Edwards RH

Lipid rafts mediate the synaptic localization of alpha-synuclein.

J Neurosci. 2004 Jul 28;24(30):6715-23.

PubMed ID
15282274 [ View in PubMed
]
Abstract

Alpha-synuclein contributes to the pathogenesis of Parkinson's disease (PD), but its precise role in the disorder and its normal function remain poorly understood. Consistent with a presumed role in neurotransmitter release and its prominent deposition in the dystrophic neurites of PD, alpha-synuclein localizes almost exclusively to the nerve terminal. In brain extracts, however, alpha-synuclein behaves as a soluble, monomeric protein. Using a binding assay to characterize the association of alpha-synuclein with cell membranes, we find that alpha-synuclein binds saturably and with high affinity to characteristic intracellular structures that double label for components of lipid rafts. Biochemical analysis demonstrates the interaction of alpha-synuclein with detergent-resistant membranes and reveals a shift in electrophoretic mobility of the raft-associated protein. In addition, the A30P mutation associated with PD disrupts the interaction of alpha-synuclein with lipid rafts. Furthermore, we find that both the A30P mutation and raft disruption redistribute alpha-synuclein away from synapses, indicating an important role for raft association in the normal function of alpha-synuclein and its role in the pathogenesis of PD.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Alpha-synucleinP37840Details